Which Countries Will Open Cannabis Markets Next?

Photo by RDNE Stock project via Pexels.

Ask someone when a country legalizes cannabis and they'll picture a single date -- a president's signature, a referendum result, a headline. That's not how it's actually playing out. Almost everywhere reform has touched down over the last five years, legalization has stalled in a middle zone: adults can possess it, sometimes grow it, occasionally join a club that grows it for them -- but they can't walk into a shop and buy it the way they'd buy a six-pack. That gap between legal possession and legal purchase is where most of the world's cannabis policy currently sits, and it's getting crowded.

Four EU countries now run some version of a club-based model -- Germany, Malta, Luxembourg, and as of January 2026, Czechia. Not one of them has cracked commercial retail. That's not an oversight; it's the compromise every one of these governments landed on to satisfy public health ministries nervous about normalization while still honoring court rulings or coalition promises to end criminal penalties. The result is a patchwork of home-grow allowances, nonprofit clubs, and personal possession limits that looks like progress on paper but leaves the actual commercial market -- pricing, quality control, tax revenue -- almost entirely unaddressed.

So the interesting question heading into 2026-2028 isn't which country legalizes next. Plenty already have, in the narrow sense. It's which one actually closes the gap between legal possession and legal purchase first, and what that finished framework looks like when it arrives. History gives us a pretty reliable script for how this usually goes: the end of US alcohol Prohibition in 1933 wasn't a single flip either, it was a state-by-state unwind that took years to sort out distribution and taxation. Colorado and Washington's 2012 legalization votes didn't produce actual retail sales until January 2014, a full year of rulemaking in between. Uruguay legalized in 2013 and didn't get pharmacy sales running until 2017. Reform happens in stages -- and right now, most of the world is stuck somewhere around stage two.

Europe's Club Model Has Hit Its Ceiling

Photo by Pixelkult via Pixabay.

As of 2026, four EU member states allow adults to possess, cultivate, and organize into cannabis social clubs without any path to walk into a commercial dispensary: Germany, Malta, Luxembourg, and now Czechia, whose new law took effect January 1, 2026. The Czech statute lets adults 21 and older grow up to three plants at home and carry up to 100 grams of dried flower -- generous by European standards, but still entirely non-commercial. Nobody is selling anybody anything legally under this framework; it's grow-your-own or join a nonprofit collective that grows it for its members.

Germany is the biggest test case simply because of scale. As of mid-2026 the country has more than 1,200 registered Cannabis Social Clubs, but approval runs through each of the 16 states individually, and the pace and rigor of that approval varies enormously -- Bavaria has been notably slower and stricter than Berlin or North Rhine-Westphalia. That inconsistency means two Germans with the same legal rights on paper can have wildly different real-world access depending on their postal code.

The structural flaw in every club model is supply math. A club's output is capped by however many plants its members can legally grow and however much labor they're willing to put into it -- there's no industrial-scale legal cultivation feeding these systems the way a licensed retail market would have. That cap means legal supply structurally can't meet demand, and the illicit market doesn't disappear, it just operates alongside the legal one, often more conveniently and just as cheaply. This is precisely the dynamic that pushed Uruguay and eventually Canada toward government or licensed commercial production rather than relying on home grows alone.

That's why the conversation among European analysts has shifted from whether commercial retail eventually arrives to when. Austria and Belgium, both of which have flirted with decriminalization but held back on full reform, are watching Germany's club rollout closely -- less to see if it works and more to see how long Germany can tolerate the gap between legal use and legal purchase before political pressure forces the next step.

Switzerland and the Netherlands Are the Templates to Watch

Photo by World Sikh Organization of Canada via Pexels.

While Germany and Czechia are experimenting with clubs, Switzerland and the Netherlands are running something structurally different: government-supervised pilot programs that involve actual licensed cultivation and actual point-of-sale transactions, just on a deliberately small and heavily monitored scale. These aren't loopholes or gray-zone tolerance policies -- they're built from the start to generate data.

That's the key distinction. A Swiss pilot city program tracks pricing against black-market rates, monitors public health indicators like emergency room visits and youth access, and follows product through licensed growers to specific pharmacies or shops with purchase caps per participant. The Netherlands' long-running coffeeshop tolerance policy has more recently added a legal cultivation supply chain pilot to finally close its own famous back-door problem -- coffeeshops could sell cannabis legally at the counter for decades, but the product arriving at the loading dock was still technically illicit until these pilots began feeding it a licensed source.

If Germany or Czechia eventually move from clubs to full retail, the Swiss structure -- licensed growers, tracked sales, limited outlets -- is the most plausible blueprint available, mostly because it already has years of operating history and real outcome data behind it, not just a legislative proposal. Regulators tend to copy what's been tested over what's merely been argued for.

The counter-case matters just as much, though. Pilot programs are deliberately slow, and Switzerland has set no firm date or trigger for scaling its program nationally -- it could stay a pilot indefinitely if the data comes back ambiguous or if political appetite cools. Treating this as an unstoppable trend line would be reading more certainty into a handful of city-level experiments than currently exists.

There's one more concrete marker to watch: the European Commission is expected to issue guidance harmonizing medicinal cannabis rules across the bloc by 2027. That's a meaningful step toward EU-wide consistency on cross-border prescriptions and product standards, but it's explicitly medical, not recreational. It won't resolve the retail question Germany and Czechia are wrestling with -- it just makes the medical side of the market a little less chaotic while the recreational side keeps sorting itself out state by state.

Mexico's Unfinished Legal Revolution

Photo by MikeCastelan via Pixabay.

Mexico is the clearest example anywhere of a court moving faster than a legislature, and then the legislature simply not catching up. The Supreme Court declared cannabis prohibition unconstitutional back in 2021 -- a sweeping ruling that should have forced Congress to build a full regulatory and retail framework within a defined window. Five years on, that framework still doesn't exist.

What Mexico has instead is a gray zone: possession for personal use is tolerated in practice, largely because the court ruling makes prosecution legally untenable, but there's no licensing system, no dispensary network, no regulated supply chain. Anyone wanting cannabis is still buying from the same informal sources that existed before 2021 -- the court changed the legal risk calculus without changing where the product actually comes from.

This isn't unique to Mexico. It's a recurring pattern across Latin America: judicial rulings or constitutional challenges outpace what legislatures are willing or able to pass into workable commercial law. Courts can strike down a prohibition; they can't design a licensing regime, set tax rates, or build an enforcement agency. That part requires legislative will, and legislative will is exactly what's been missing in Mexico City since 2021, through multiple changes in congressional priorities and competing legislative agendas.

There's a useful American parallel here, even though it runs through a different branch of government. US states started legalizing cannabis commercially back in 2012, yet basic financial infrastructure -- interstate banking access for cannabis businesses, routine treatment under federal tax code -- is still unresolved at the federal level well over a decade later; the SAFE Banking Act has been introduced and stalled repeatedly in Congress since 2019. The lesson transfers directly: a landmark legal decision, whether from a court or a state ballot initiative, doesn't guarantee the follow-through legislation arrives on any predictable timeline. Political stalling can outlast the reform's own momentum.

What makes Mexico worth watching anyway is what's sitting underneath the stalled politics. It borders the largest cannabis consumer market in the world, and it already has substantial agricultural capacity and export experience in produce and other crops that could plausibly redirect toward cannabis cultivation at real scale. If Congress ever does pass a retail framework, Mexico could scale up faster than almost anywhere else discussed here -- the infrastructure gap is smaller than the political one.

Colombia and Brazil: Medical and Judicial Roads to the Same Place

Photo by Julian via Unsplash.

Colombia has been chipping away at this problem longer than almost any other country in the region. Personal possession has been decriminalized since 1994, medicinal cannabis was legalized in 2016, and industrial hemp followed in 2021 -- that's three decades of incremental legal groundwork, longer than the club-model experiments happening in Europe right now.

That head start shows up most clearly in infrastructure. Colombia built out large-scale cultivation operations aimed at export-grade medical cannabis for international pharmaceutical markets, and that greenhouse and processing capacity doesn't disappear if recreational law changes -- it's already sitting there, permitted and operating, waiting for a legal recreational market to sell into. Legislators have pushed constitutional amendments to Article 49 to strip cannabis from the country's prohibited-substances language entirely, but those efforts have repeatedly failed to clear the supermajority threshold required for constitutional change, so recreational commercial sale remains illegal even with the cultivation capacity ready to serve it.

Brazil is following a track that looks more like Mexico's than Colombia's. Its Supreme Court, not Congress, set personal-use possession thresholds -- up to 40 grams of flower or six plants -- through a judicial ruling rather than legislation. That's the same judiciary-ahead-of-legislature sequence playing out in Mexico, just with different numbers attached, and it leaves Brazil in a similar gray zone: individual use is protected, commercial retail is not addressed at all.

Zoom out and the regional pattern is remarkably consistent: decriminalize personal use first, legalize medical cannabis second, then hit a legislative wall before recreational retail ever gets seriously debated. Colombia is furthest along that sequence and has the manufacturing base to move quickly if the wall ever breaks. Brazil is earlier in the sequence, with judicial protection for users but no legislative machinery yet built to handle a commercial market. Neither is likely to have functioning recreational retail before the end of the decade, but Colombia's existing infrastructure means it wouldn't need years of buildout once the legal barrier finally comes down -- unlike a country starting from zero.

South Africa and Thailand: Two Diverging Paths

Photo by Hoài Nam via Pexels.

South Africa and Thailand make an instructive pair precisely because they show two different ways this process can go once possession gets legalized ahead of a retail structure.

South Africa's Constitutional Court ruled in 2018 that criminalizing private adult cannabis use was unconstitutional, and it took until February 2024 for legislation -- the Cannabis for Private Purposes Act -- to formally codify possession and cultivation rights for adults 18 and older in private spaces. That's the judicial-first pattern again, the same sequence seen in Mexico and Brazil: court acts, legislature eventually codifies personal use, and commercial retail sits untouched on the other side of that line. Six years between the ruling and the codifying statute is itself a data point on how long this gap can persist even when the court's directive is unambiguous.

Thailand took the opposite route and offers the cautionary half of this story. It decriminalized cannabis in 2022 in a fast, headline-grabbing move that opened thousands of dispensary-style shops almost overnight, with essentially no product standards, no clear THC labeling regime, and minimal enforcement infrastructure in place before the market opened. The predictable result has been regulatory whiplash -- reports of unregulated potency, youth access concerns, and tourism-driven backlash have pushed Thai authorities back toward tighter restrictions, effectively partially reversing course rather than building out the missing regulatory layer after the fact.

The contrast is the useful part for anyone trying to read where the next successful market opens. Thailand shows that speed without infrastructure isn't free -- legalizing retail access before quality control, age verification, and enforcement systems exist can generate enough public backlash to force a partial retreat, wasting the political capital that opened the market in the first place. South Africa's slower, court-then-statute sequence hasn't produced retail access either, but it also hasn't produced a backlash requiring reversal. For investors and policymakers watching from outside, that's the real lesson: the fastest mover isn't necessarily the safest bet, and a market that opens in stages with enforcement built in tends to be more durable than one that opens all at once.

Why US Capital Markets Are Part of This Story

Photo by Pixabay via Pexels.

None of this international maneuvering happens in a vacuum -- a lot of it is being watched against what's happening in US capital markets, because that's the clearest available signal of whether institutional finance is willing to treat cannabis like a normal industry.

The DEA's move to reclassify cannabis to Schedule III for state-licensed medical products set off a chain reaction that culminated in actual major-exchange listings: Trulieve listed on the NYSE in June 2026, followed by Glass House Brands on June 30, 2026. These aren't small over-the-counter tickers anymore -- they're companies now subject to the same listing standards, disclosure requirements, and institutional scrutiny as any conventional agribusiness or pharmaceutical stock. That's a meaningfully different level of legitimacy than the cannabis sector has had at any prior point in US history.

What makes this relevant well beyond US borders is that it functions as a legitimacy signal for regulators designing frameworks elsewhere. Germany's policymakers, Czechia's, and eventually Mexico's are all watching how mainstream capital absorbs cannabis equities, because it tells them whether a fully commercial legal market can attract the kind of institutional investment that makes tax revenue projections and job creation numbers actually credible rather than aspirational. A retail framework that can plausibly attract pension-fund-adjacent capital is a much easier political sell domestically than one that only ever attracts speculative money.

The caveat here matters as much as the headline. US federal law still doesn't permit interstate cannabis commerce, and recreational products -- as opposed to Schedule III medical formulations -- still can't list on major exchanges under current federal law. What happened with Trulieve and Glass House Brands is a partial, medical-only signal of capital-market normalization, not proof that a fully recreational market anywhere is about to get the same access to institutional capital. Reading it as a green light for recreational markets abroad would be overstating what actually changed. It's real progress, but it's progress with a fairly narrow scope, and the countries watching it closely understand that distinction even if the headlines sometimes blur it.

Line up Europe, Latin America, and southern Africa side by side and the same sequence keeps repeating: a court ruling or a referendum forces the possession question open, legislatures then stall on the harder work of building a retail framework, and the black market simply keeps operating in whatever space that stall leaves behind. Mexico's five-year gap since its Supreme Court ruling, Brazil's judicially-set possession thresholds with no commercial follow-up, South Africa's six years between ruling and codifying statute -- these aren't isolated flukes, they're the same bottleneck showing up on three different continents. That gap, not the next legalization headline, is where the real action sits through 2027 and 2028.

If there's a single template worth actually betting on, it's Switzerland's pilot structure -- not because it's fast, but because it isn't. Licensed cultivation, tracked sales, limited outlets, years of accumulating public-health and pricing data before anyone talks about scaling nationally: that's the opposite of Thailand's overnight rollout, and it's the approach regulators tend to trust precisely because it produces evidence instead of just promises.

Worth remembering, too, that the countries best positioned to close this gap aren't necessarily the ones with the most permissive laws on the books today. They're the ones with something concrete already built underneath the legal question -- Colombia's export-grade cultivation infrastructure sitting idle for a recreational market that doesn't legally exist yet, Germany's access to normalizing capital markets even without a domestic retail law, Mexico's agricultural capacity and border proximity to the world's biggest consumer base. Legal permission is necessary but it's clearly not sufficient. The country that finishes this race first will be the one that had the plumbing in place before the law caught up to it -- not the one that changed the law first and hoped the plumbing would follow.